Early functional outcome after IV rTPA administration in Egyptian acute ischemic stroke patients

Table 1 Demographic and baseline characteristics of both groups

		Group I		Group II		X² value	P value
		N	%	N	%		P value
Age		60.24 ± 9.37		58.81 ± 13.31			0.37
Male		51	68.0	62	54.4	3.487	0.062
Hypertension		49	65.3	62	54.4	2.237	0.135
Cardiac diseases	IHD^$	24	32	31	27.2	0.507	0.477
	RHD^†	5	6.7	7	6.1	0.021	1
	AF^‡	12	16	28	24.6	1.987^a	0.159
Smoker		24	32	27	23.7	1.588	0.208
Cerebrovascular ischemic event	Stroke	12	16	25	21.9	2.636	0.450
	TIA	5	6.7	3	2.6
	TIA + stroke	1	1.3	2	1.8
Diabetes Mellitus		27	36	40	35.1	0.016	0.898
Hyperlipidemia		28	37.3	35	30.7	0.882	0.348
Stroke Severity	Mild (NIHSS^\|\| 0–8)	21	28.0	43	37.7	1.920	0.383
	Moderate (NIHSS^\|\| 9–15)	37	49.3	48	42.1
	Severe (NIHSS^\|\| ≥ 16)	17	22.7	23	20.2
TOAST classification	Large vessel	15	20.0	20	17.5	0.187	0.6658
	Cardioembolic	24	32.0	44	38.6	0.851	0.3563
	small vessel	12	16.0	15	13.2	0.288	0.5917
	Others	24	32.0	35	30.7	0.035	0.8507
OCSP^¶ classification	TACS^**	35	46.7	34	29.8	5.545	0.0185*
	PACS^††	24	32.0	60	52.6	7.734	0.0054*
	LACS^‡‡	14	18.7	15	13.2	1.046	0.3065
	POCS^§§	2	2.7	5	4.4	0.363	0.5471

*P value ˂0.05 is significant, ^$ischemic heart disease, ^†rheumatic heart disease, ^‡atrial fibrillation, ^§ transient ischemic attack, ^||National institute of health, ^¶Oxfordshire Community Stroke Project, ^**total anterior circulation syndrome, ^††partial anterior circulation syndrome, ^‡‡lacunar syndrome, ^§§posterior circulation syndrome